S2. Genetic Heterogeneity of Human ~-Galaetosidase Deficiency: Yoshiyuki SUZUKI
(Dept. Pediat., Univ. Tokyo, Tokyo) Acid ~-galactosidase is known to be deficient in two different hereditary metabolic diseases; Gm-gangliosidosis and Krabbe disease. The deficient enzymes have different substrate specificities in these diseases. Furthermore ~-galactosidase activity is affected by various environmental factors in many tissues and cells. A secondary deficiency of this enzyme has been recorded in several lysosomal diseases. These include mucopolysaccharidoses and mucolipidoses. For the past several years we collected the following patients with ~-galactosidase deficiency, primary or secondary.
1. G~-gangliosidosis 14 cases 2. Krabbe disease (globoid cell leukodystrophy) 13
3. Mucopolysaccharidoses (autopsy cases only) 2
Mucolipidosis II 12
5. /3-Galactsidase-neuraminidase deficiency 12
The deficient/3-galactosidase had the same substrate specificity in all diseases other than globoid cell leukodystrophy.
Under the diagnosis of G.~t-gangliosidosis exceptional cases have been found. Two adult sibling cases, 34 and 30 years old, had a slowly progressive pyramidal and extrapyramidal disease since 9 years of age. Gait disturbance, blephalospasm, neck rigidity, dysphagia and dysarthria were observed at the time of admission. Facial grimacing was observed occasionally. There were no involuntary movements of extremities or convulsive seizures. Corneal opacity and bilateral cataracts were found. Cherry-red spots were absent. Facies was apathetic but not of gargoyle-like appearance. Urinary mucopolysaccharides were normal. They showed a generalized deficiency of ~-galactosidase both toward synthetic substrates and Gin. Accumulation of Gm was found by ~4o-galactose uptake experiment in cultured skin fibroblasts. The hybrid cells of these adult patients and a typical infantile Gm-gangliosidosis failed to show a complementation of /%galacto-sidase activity. This result suggests that these two types of patients have allelic gene mutations. The molecular basis of the mutations in these patients with quite different clinical manifestations is not known. Apparently the residual enzyme activity was higher in adult patients and a different rate of degradation of substrates may explain this problem. Currently these adults are classified as having G~-gangliosidosis (adult type).
Many adult patients with cerebellar ataxia, myoclonus, cherry-red spots and gargoylelike dysmorphism have been reported in Japan. Urinary mucopolysaccharides were normal in these patients. /%Galactosidase activity was low in leukocytes, fibroblasts, liver and brain, but was normal in plasma. The residual enzyme was more thermostable and less activated by chloride ions. Apparent K~ and pH optima were not shifted. These Biochemical analysis of liver stored for a day at --25~ indicated an increased hepatic glycogen content at 8.5~ and normal activity of G-6-Pase (4.5 ~mol P~/min/g liver).
These findings were thought to be compatible with glycogen storage disease Type Ib.
At the age of 3 years, a surgical operation of mesentericocaval shunt was performed, because she had repeated episodes of severe hypoglycemia, metabolic acidosis and recurrent infections requiring frequent hospitalization. The following studies were performed with the use of a liver specimen obtained at the operation.
Assay of G-6-Pase in fresh liver from the patient gave low activity (0.8/2mol/min/g liver)
in the absence of detergent, but was normal (10.2/~mol/min/g liver) after addition of detergent. In patients with glycogen storage disease Type Ia, G-6-Pase activity was very low both with and without detergent. These findings suggest a defect in G-6-P transport in the microsomal membrane of the patient's liver.
Gluconeogenesis from glycerol was studies in liver slices from the patient, a patient with glycogen storage disease Type Ia and controls. Both patient Y.S. and a patient with glycogen storage disease Type Ia showed increased conversion of 14C glycerol to glycogen compared with controls. There was no rise of glucose during the incubation in patient Y.S.
or the patient with glycogen storage Type Ia, whereas controls showed a marked increase in glucose after incubation.
The resuIts from patient Y.S. suggest that sufficient activity of G-6-Pase is present in microsome, both in vitro and in vivo as judged by the results of the functional tests and the results of the experiments with liver slice. The masking phenomenon observed in the intact microsomes of the patient can be explained by the lack of a G-6-P transport system. disease Type Ib, the extra respiration was diminished, indicating a reduction of the oxygendependent metabolic burst of phagocytes. A possible role for G-6-P transport system in neutrophile function was discussed on the basis of these data described in the literature.
